Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)We described the selection of a novel nucleic acid antibody-like prostate cancer (PCa) that specifically binds to the single-stranded DNA molecule from a 277-nt fragment that may have been partially paired and bound to the PCA3 RNA conformational structure. PCA3-277 aptamer ligands were obtained, and the best binding molecule, named CG3, was synthesized for validation. Aiming to prove its diagnostic utility, we used an apta-qPCR assay with CG3-aptamer conjugated to magnetic beads to capture PCA3 transcripts, which were amplified 97-fold and 7-fold ...
Prostate cancer (PCa) is the most common cancer in men. It is a heterogeneous disease and currently ...
Serum PSA has shown to be the most valuable tool in the detection, staging and monitoring of prostat...
Prostate Cancer (PCa) is the second most diagnosed cancer in men across the world; it is considered ...
[[abstract]]The older population increases due to advances in medical technology. This leads to the ...
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvime...
Prostate cancer (PCa) is an important public health problem with increasing incidence and mortality...
The most common prostate cancer (PCa) diagnostics which is based on detection of prostate-specific a...
Currently, PSA is considered the most sensitive marker available for prostate cancer detection and f...
One of the major challenges in the development of targeted nanoparticles (NPs) for cancer therapy is...
Background: PCA3 is a long noncoding RNA (lncRNA) with unknown function, upregulated in prostate can...
Targeting specifically primary prostate cancer (PCa) cells for immune therapy, gene therapy or molec...
BACKGROUND: Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer...
Prostate cancer (PCa) is one of the most common malignancies in men and seriously threatens men’s he...
This work is a continuation of our research into the development of simple, reliable, and cost-effec...
Prostate-specific membrane antigen (PSMA) is a well-characterized tumor marker associated with prost...
Prostate cancer (PCa) is the most common cancer in men. It is a heterogeneous disease and currently ...
Serum PSA has shown to be the most valuable tool in the detection, staging and monitoring of prostat...
Prostate Cancer (PCa) is the second most diagnosed cancer in men across the world; it is considered ...
[[abstract]]The older population increases due to advances in medical technology. This leads to the ...
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvime...
Prostate cancer (PCa) is an important public health problem with increasing incidence and mortality...
The most common prostate cancer (PCa) diagnostics which is based on detection of prostate-specific a...
Currently, PSA is considered the most sensitive marker available for prostate cancer detection and f...
One of the major challenges in the development of targeted nanoparticles (NPs) for cancer therapy is...
Background: PCA3 is a long noncoding RNA (lncRNA) with unknown function, upregulated in prostate can...
Targeting specifically primary prostate cancer (PCa) cells for immune therapy, gene therapy or molec...
BACKGROUND: Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer...
Prostate cancer (PCa) is one of the most common malignancies in men and seriously threatens men’s he...
This work is a continuation of our research into the development of simple, reliable, and cost-effec...
Prostate-specific membrane antigen (PSMA) is a well-characterized tumor marker associated with prost...
Prostate cancer (PCa) is the most common cancer in men. It is a heterogeneous disease and currently ...
Serum PSA has shown to be the most valuable tool in the detection, staging and monitoring of prostat...
Prostate Cancer (PCa) is the second most diagnosed cancer in men across the world; it is considered ...